---
title: "Legend Biotech announces annual general meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296264408.md"
description: "Legend Biotech has scheduled its Annual General Meeting for September 24, 2026, in Bridgewater, New Jersey. Key agenda items include receiving audited financial statements for the year ended December 31, 2025, and voting to ratify Ernst & Young LLP as the independent auditor for the fiscal year ending December 31, 2026. Additionally, shareholders will vote on the re-election of four Class III directors for three-year terms and a proposal to expand the 2020 Restricted Shares Plan reserve by 19,100,000 ordinary shares."
datetime: "2026-08-18T20:02:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296264408.md)
  - [en](https://longbridge.com/en/news/296264408.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296264408.md)
generator: "portal-rs"
---

# Legend Biotech announces annual general meeting

-   Legend Biotech schedules its annual general meeting in Bridgewater, New Jersey on Sept. 24, 2026. \* Shareholders will receive the audited consolidated financial statements for the year ended Dec. 31, 2025. \* Vote set on ratifying Ernst & Young LLP as independent auditor for the year ending Dec. 31, 2026. \* Ballot includes re-election of four Class III directors for new three-year terms. \* Proposal seeks to expand the 2020 Restricted Shares Plan reserve by 19,100,000 ordinary shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-005623), on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [LEGN.US](https://longbridge.com/en/quote/LEGN.US.md)

## Related News & Research

- [Legend Biotech CEO Alan Bash joins Morgan Stanley Global Healthcare Conference fireside chat](https://longbridge.com/en/news/297649230.md)
- [Will Legend Biotech’s (LEGN) Move to Q2 Profitability Reshape Its Investment Narrative?](https://longbridge.com/en/news/296957090.md)
- [Oculus announces annual shareholder meeting](https://longbridge.com/en/news/297894904.md)
- [GEE Group announces virtual annual shareholder meeting](https://longbridge.com/en/news/297563780.md)
- [Vantiva announces combined shareholders meeting](https://longbridge.com/en/news/297806817.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**